Herbalife Ltd (HLF)
(Real Time Quote from BATS)
$5.43 USD
+0.04 (0.74%)
Updated Feb 5, 2025 10:54 AM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HLF 5.43 +0.04(0.74%)
Will HLF be a Portfolio Killer in February?
Zacks Investment Research is releasing its prediction for HLF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HLF
CVS Health's Pre-Q4 Earnings: Time to Buy, Hold or Sell the Stock?
Should Walgreens Stock Be in Your Portfolio Before Q1 Earnings?
HLF: What are Zacks experts saying now?
Zacks Private Portfolio Services
CVS Stock Trades Near 52-Week Low: Should You Buy the Dip?
CVS' High Utilization & MBR to Cut 2024 Profits: Is the Stock a Sell?
Estimates for CVS Southbound After Rocky Q3: How to Play the Stock
Other News for HLF
March 14th Options Now Available For Herbalife (HLF)
Herbalife: Down In The Dumps, But Maybe Worth Exploring
Bill Ackman Says Hindenburg Research Closing 'A Big Loss,' Praises Short Seller's Contribution To Markets: 'Short Selling Is Really Hard'
Herbalife price target lowered to $7 from $9 at Mizuho
Herbalife price target lowered by $2 at Mizuho, here's why